Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
KC Allen Chan, YMD Lo, Wing Cheong Chan, John Wong(Chinese University of Hong Kong), Rossa W. K. Chiu(Chinese University of Hong Kong), Stephen L. Chan(Chinese University of Hong Kong), Gary J. W. Liao, Yama W. L. Zheng(Chinese University of Hong Kong), Anthony T.�C. Chan(Chinese University of Hong Kong), Peiyong Jiang(Chinese University of Hong Kong), Hao Sun(Guangzhou Institutes of Biomedicine and Health), Shing Shun N Siu(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong)
Cited by 489
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k